C. Randall Harrell, M.D.
Chairman, CEO & CMO
C. Randall Harrell, M.D. is the Founder, Chairman, and CEO of Regenerative Processing Plant, LLC. He has worked for over 30 years to become a pioneer and visionary in the field of regenerative medicine where his discoveries and patented platform technologies in the study of Type III human collagen, stem cells, pericytes, exosomes, and novel bioengineered placental derived biomaterials have lead to the developments of first in class clinically proven regenerative medicine therapies.
Dr. Harrell started his career as a research scientist at Emory University, studying immunology. He was recruited after medical school by Dr. Michael E DeBakey, the Father of Cardiovascular Surgery, to study at the largest medical center in the world, the Texas Medical Center. He did his general surgery and plastic surgery training there as well as ran a large burn and wound unit at the Michael E. DeBakey VA. Dr. Harrell also did a research fellowship in regenerative medicine where he developed the first patented regenerative human Type III Human collagen dermal filler. He is a Board Certified Plastic Surgeon and a member of ASPS and ASAPS. In addition to RPP, he is the Founder, Chairman, and CEO of Albiorex and Regenerative Medicine International.
Dr. Harrell has co-authored numerous scientific papers and books about regenerative medicine and has lectured extensively in the US and Internationally. He also has multiple issued novel patents in the field of regenerative medicine. Dr. Harrell was nominated for the Nobel Peace Prize for his medical missionary work in Central America.
Marissa Morris, PhD
VP of Marketing and Business Development
A former news anchor for major network affiliates, our spokesperson, press representative and media (video, still and audio) producer. Marissa seeks out new business pathways to make money and bring Dr. Harrell’s vision to fruition.
Patrea L. Pabst, J.D.
Patent Attorney
Patrea L. Pabst’s practice focuses on patent issues relating to biotechnology, medical, pharmaceutical, and chemical technology.
Ms. Pabst‘s practice is primarily with universities, start-up companies, and investors in start-up and early stage companies. Her practice includes evaluation of technology to assess patentability and valuation; freedom to operate opinions; prosecution in the U.S. Patent Office and coordination of corresponding foreign filings; strategic planning for the company’s long term goals; and defensive work (including reexamination and reissue applications and interference proceedings in the U.S. and oppositions in the European and Japanese Patent Offices).
Ms. Pabst spent nine years in medical research prior to beginning her practice. She has authored numerous articles and book chapters, as well as being an inventor on her own patents. She is a member of the Health Care Advisory Council and is a contributing author to the Journal of Tissue Engineering.